BIVI BioVie Pharma Total Asset Value of Company

BIVI (biovieinc.com) - company brandmark

The market price confirmed by the chart shows BioVie Inc. (BIVI) total assets at 17.94. The business relies on exclusive rights for combating liver inflammation, which, combined with strict FDA oversight, limits competition. BioVie Inc. (BIVI) is also building intellectual capital for dementia therapy; however, contractor errors during testing have triggered litigation and an acute liquidity shortage.

BIVI (BioVie) Company Total Assets history from 07/04/2022 to 10/29/2026

Analytical breakdowns and data insights for company biovieinc.com (BIVI)

- current quotes and average value forecast:
Market Chart BioVie|BIVI - Price Target Chart
- market capitalization data:
Market Valuation BIVI|BIVI - Enterprise Value
- issuer book value statistics:
Accounting Value of a Share BioVie|BIVI - Book Capitalization|Market Capitalization to Book Value Ratio biovieinc.com|BIVI - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio BioVie Inc.|BIVI - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio BioVie|BIVI - Company Aggregate Debts|Debts to Book Capitalization BIVI|BIVI - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings BioVie|Quick Liquidity biovieinc.com
- net income and valuation multiples indicators:
BIVI - Net Profit
Fundamental valuation:BioVie Inc.
Manufactured products of BioVie Inc

A comparative analysis of total resources allows investors to assess the scale of the business, where this metric, calculated inversely via ROA, captures the total value of the organization's assets and liabilities. The trend in the company's total assets reflects the capitalization of intellectual property and the costs of clinical trials for the NE3107 molecule, determining the potential for future licensing deals for BioVie Inc. (BIVI).

Key competitors

ARWR - Company Total Asset Base|Aggregate Company Assets Mirum|Dynavax - Total Asset Value of Company|Company Total Assets ABUS|IVA (Inventiva Corp) - Aggregate Asset Value|Company Total Assets GYRE (Gyre Therapeutics, Inc.)|Company Total Assets assemblybio.com ASMB|GALT - Aggregate Company Assets|Aggregate Asset Value GNFT (Genfit S.A.)|durect.com (DRRX) - Aggregate Company Assets|Cumulative Company Assets Aligos Therapeutics, Inc.|GLMD (Galmed Pharmaceuticals Ltd) - Company Total Assets|Company Total Assets endrainc.com|Cumulative Company Assets HEPA (Hepion Pharmaceuticals)